1. Home
  2. DVAX vs CDLR Comparison

DVAX vs CDLR Comparison

Compare DVAX & CDLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$15.50

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Cadeler AS

CDLR

Cadeler AS

HOLD

Current Price

$24.35

Market Cap

1.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DVAX
CDLR
Founded
1996
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
DVAX
CDLR
Price
$15.50
$24.35
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$26.50
N/A
AVG Volume (30 Days)
2.6M
151.4K
Earning Date
02-20-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2505.89
EPS
N/A
0.90
Revenue
$330,514,000.00
$632,099,026.00
Revenue This Year
$24.63
$144.16
Revenue Next Year
$15.85
$69.44
P/E Ratio
N/A
$6.71
Revenue Growth
26.73
198.94
52 Week Low
$9.20
$15.37
52 Week High
$15.73
$25.21

Technical Indicators

Market Signals
Indicator
DVAX
CDLR
Relative Strength Index (RSI) 76.15 63.62
Support Level $15.46 $23.02
Resistance Level $15.59 $24.23
Average True Range (ATR) 0.06 0.58
MACD -0.16 -0.06
Stochastic Oscillator 15.22 63.31

Price Performance

Historical Comparison
DVAX
CDLR

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

About CDLR Cadeler AS

Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.

Share on Social Networks: